Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Lightpath Technologies
LPTH
$824M
| $367K | ﹤0.01% |
+129,700
| New | +$228K |
|
2827
Champion Homes
SKY
$5.1B
| $367K | ﹤0.01% |
103,100
+8,700
| +9% | +$28K |
|
|
STRS
2828
DELISTED
STRATUS PPTYS INC
STRS
| $367K | ﹤0.01% |
18,000
+2,100
| +13% | +$35.1K |
|
|
FCRE
2829
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
| $366K | ﹤0.01% |
162,760
+14,740
| +10% | +$32.9K |
|
2830
ImmuCell
ICCC
$99.3M
| $360K | ﹤0.01% |
47,800
+2,600
| +6% | +$18.3K |
|
|
GLF
2831
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $360K | ﹤0.01% |
77,112
-289,200
| -79% | -$1.77M |
|
2832
EVI Industries
EVI
$206M
| $359K | ﹤0.01% |
86,200
+1,400
| +2% | +$5.34K |
|
|
CCXI
2833
DELISTED
ChemoCentryx, Inc.
CCXI
| $359K | ﹤0.01% |
44,300
+19,600
| +79% | +$139K |
|
2834
MediWound
MDWD
$179M
| $356K | ﹤0.01% |
5,957
+2,271
| +62% | +$143K |
|
|
SUMR
2835
DELISTED
Summer Infant, Inc.
SUMR
| $356K | ﹤0.01% |
17,756
-852
| -5% | -$14.6K |
|
2836
Upland Software
UPLD
$14.9M
| $355K | ﹤0.01% |
5,039
+1,999
| +66% | +$151K |
|
|
ADAP
2837
DELISTED
Adaptimmune Therapeutics
ADAP
| $353K | ﹤0.01% |
+29,300
| New | +$287K |
|
|
PACD
2838
DELISTED
Pacific Drilling S A
PACD
| $353K | ﹤0.01% |
42,040
-2,480
| -6% | -$32.8K |
|
|
GZT
2839
DELISTED
Gazit-globe Ltd
GZT
| $352K | ﹤0.01% |
39,200
+2,200
| +6% | +$22.3K |
|
2840
RAVE Restaurant Group
RAVE
$43.9M
| $351K | ﹤0.01% |
54,900
-10,400
| -16% | -$74K |
|
2841
First US Bancshares
FUSB
$90.6M
| $350K | ﹤0.01% |
39,200
+5,200
| +15% | +$43.3K |
|
2842
Mind CTI
MNDO
$20.6M
| $350K | ﹤0.01% |
138,375
-17,025
| -11% | -$45.1K |
|
|
WIRE
2843
DELISTED
Encore Wire Corp
WIRE
| $350K | ﹤0.01% |
+9,437
| New | +$382K |
|
|
HSNI
2844
DELISTED
HSN, Inc.
HSNI
| $350K | ﹤0.01% |
6,900
-29,500
| -81% | -$1.61M |
|
2845
MediciNova
MNOV
$65.5M
| $349K | ﹤0.01% |
98,200
-4,900
| -5% | -$15.6K |
|
|
CBIO
2846
Crescent Biopharma
CBIO
$610M
| $348K | ﹤0.01% |
609
+131
| +27% | +$86.8K |
|
|
BCRH
2847
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $348K | ﹤0.01% |
20,300
-1,700
| -8% | -$29.6K |
|
|
GFED
2848
DELISTED
Guaranty Federal Bancshares In
GFED
| $346K | ﹤0.01% |
22,700
+2,900
| +15% | +$42.8K |
|
|
TRT
2849
Trio-Tech International
TRT
$118M
| $345K | ﹤0.01% |
247,400
+2,200
| +0.9% | +$3.01K |
|
|
TBRA
2850
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $345K | ﹤0.01% |
34,365
-2,700
| -7% | -$28K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.